#USA #New York #Class Action #Bronstein Gewirtz #Charming Medical

Legal Action Initiated Against Charming Medical Ltd.

In a significant move for shareholder rights, Bronstein, Gewirtz & Grossman LLC, a prominent law firm dedicated to protecting investor interests, has filed a class action lawsuit against Charming Medical Ltd. (NASDAQ MCTA). This action is directed at individuals and entities that invested in Charming Medical between October 10, 2025, and November 12, 2026. The firm is calling on affected investors to come forward and join this legal battle.

Allegations Against Charming Medical Ltd.

The lawsuit claims that during the specified class period, Charming Medical and its executives acted in ways that severely misled investors. According to the complaint, the defendants failed to disclose crucial information about the company, which included:

1. Fraudulent Stock Promotion: Charming Medical was purportedly involved in a deceptive stock promotion scheme, heavily reliant on misinformation spread via social media platforms. In addition, impersonators posing as financial professionals reportedly contributed to this scheme, which aimed to artificially inflate the stock price.

2. Insider Trading Activities: Insiders and affiliates allegedly utilized offshore or nominee accounts for coordinated stock dumping during periods of planned price inflation, further complicating the stock's valuations and deceiving investors.

3. Misleading Public Statements: The lawsuit contends that Charming Medical made several public statements and risk disclosures that omitted necessary information regarding the false rumors and manipulative trading activities impacting the stock's value. These omissions rendered the corporation's positive messages about its business operations and future prospects materially misleading.

The firm highlights how these actions not only hindered investor trust but also created a façade of success that did not genuinely reflect the company's health.

Next Steps for Investors

For investors who believe they were impacted by these alleged deceptions, the firm advises you to act swiftly, as the deadline to apply for lead plaintiff status is February 17, 2026. Regardless of whether you choose to seek this designation, the opportunity to recover losses remains open to all class members under the lawsuit.

Further details, including access to the filed complaint, can be found on Bronstein, Gewirtz & Grossman’s website at bgandg.com/MCTA.

No Upfront Costs for Affected Investors

Investors can rest assured as their legal representation will be on a contingency fee basis. This arrangement ensures that the firm only recoups expenses and fees if they achieve a successful outcome. This model underscores their commitment to recovering funds for investors without imposing initial financial burdens.

About Bronstein, Gewirtz & Grossman, LLC

Recognized nationally for its efforts in securing shareholder interests, Bronstein, Gewirtz & Grossman, LLC has a proven track record in recovering significant amounts for victims of securities fraud. As emphasized by Peretz Bronstein, the Founding Partner, their mission remains centered on restoring investor capital while holding corporations accountable for their actions.

For continuous updates, stakeholders are encouraged to follow the firm on social media platforms like LinkedIn, X (formerly Twitter), Facebook, and Instagram. Interested parties can also reach out directly for inquiries at 917-590-0911 or via email at [email protected].

This situation surrounding Charming Medical captures the ongoing challenges faced by investors in the current market environment. As the legal proceedings unfold, affected parties are urged to explore their rights and consider joining this class action to seek justice and potential recovery for alleged losses incurred.